RecallDepth
Class II Ongoing

Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, a) 100 ct. bottle (NDC 70010-492-01) and 500 ct. bottle (NDC 70010-492-05), Manufactured for: Granules Pharmaceutical Inc., Chantilly, VA, Manufactured by: Granules India Limited, Hyderabad - 500-081, India

Company
Granules Pharmaceuticals Inc.
Recall Initiated
July 3, 2020
Posted
July 22, 2020
Recall Number
D-1386-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 476,073 bottles; b) 2,100 bottles
Firm Location
Chantilly, VA, United States

Reason for Recall

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Distribution

US Nationwide

Lot / Code Info

a) 100 count 4920003A/May-21 4920004A/Jun-21 4920005A/Jun-21 4920009A/Nov-21 4920010A/May-22 4920011A/Jun-22 4920012A/Jun-22 4920013A/Jul-22 4920014A/Jul-22 4920015A/Aug-22 4920016A/Jan-23 b) 500 count 4920005B/Jun-21

More recalls by Granules Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls